Cargando…

Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study

BACKGROUND: Toxicology studies have identified pregnancy as a window of susceptibility for endocrine disrupting chemicals (EDCs) and cardiometabolic indices in women. No study in humans, however, has examined EDC mixtures and cardiometabolic indices during pregnancy. METHODS: We used the Health Outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuong, Ann M., Braun, Joseph M., Sjödin, Andreas, Calafat, Antonia M., Yolton, Kimberly, Lanphear, Bruce P., Chen, Aimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393591/
https://www.ncbi.nlm.nih.gov/pubmed/34425642
http://dx.doi.org/10.1016/j.envint.2021.106747
_version_ 1783743760319905792
author Vuong, Ann M.
Braun, Joseph M.
Sjödin, Andreas
Calafat, Antonia M.
Yolton, Kimberly
Lanphear, Bruce P.
Chen, Aimin
author_facet Vuong, Ann M.
Braun, Joseph M.
Sjödin, Andreas
Calafat, Antonia M.
Yolton, Kimberly
Lanphear, Bruce P.
Chen, Aimin
author_sort Vuong, Ann M.
collection PubMed
description BACKGROUND: Toxicology studies have identified pregnancy as a window of susceptibility for endocrine disrupting chemicals (EDCs) and cardiometabolic indices in women. No study in humans, however, has examined EDC mixtures and cardiometabolic indices during pregnancy. METHODS: We used the Health Outcomes and Measures of the Environment (HOME) Study to examine whether bisphenol A (BPA), polybrominated diphenyl ethers (PBDEs), per- and polyfluoroalkyl substances (PFAS), and phthalates are associated with blood pressure, glucose, and lipids in 388 pregnant women. We measured PBDEs and PFAS in serum at 16 weeks gestation, while BPA and phthalate metabolites were quantified in urine at 16 and 26 weeks gestation. We used linear regression and Bayesian Kernel Machine Regression (BKMR) to estimate covariate-adjusted associations of individual EDCs and their mixtures with cardiometabolic indices during pregnancy. RESULTS: A 10-fold increase in BDE-28 was associated with a 13.1 mg/dL increase in glucose (95% Confidence Interval [CI] 2.9, 23.2) in linear regression. The BKMR model also identified BDE-28 as having a positive association with glucose. BDE-28, BDE-47, and BDE-99 were positively associated with total cholesterol in both single- and multi-pollutant models, whereas a suggestive negative association was noted with BDE-153. Mono-n-butyl phthalate (MBP) (β = −7.9 mg/dL, 95% CI −12.9, −3.0) and monobenzyl phthalate (MBzP) (β = −6.3 mg/dL, 95% CI −10.6, −2.0) were both associated with significant decreases in cholesterol in linear regression, but only MBzP was identified as an important contributor in the BKMR model. CONCLUSION: Overall, we observed positive associations between PBDEs with glucose and cholesterol levels during pregnancy, while negative associations were found between some phthalate biomarkers and cholesterol. No relationship was noted for BPA or PFAS with cardiometabolic indices during pregnancy across both models.
format Online
Article
Text
id pubmed-8393591
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-83935912021-11-01 Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study Vuong, Ann M. Braun, Joseph M. Sjödin, Andreas Calafat, Antonia M. Yolton, Kimberly Lanphear, Bruce P. Chen, Aimin Environ Int Article BACKGROUND: Toxicology studies have identified pregnancy as a window of susceptibility for endocrine disrupting chemicals (EDCs) and cardiometabolic indices in women. No study in humans, however, has examined EDC mixtures and cardiometabolic indices during pregnancy. METHODS: We used the Health Outcomes and Measures of the Environment (HOME) Study to examine whether bisphenol A (BPA), polybrominated diphenyl ethers (PBDEs), per- and polyfluoroalkyl substances (PFAS), and phthalates are associated with blood pressure, glucose, and lipids in 388 pregnant women. We measured PBDEs and PFAS in serum at 16 weeks gestation, while BPA and phthalate metabolites were quantified in urine at 16 and 26 weeks gestation. We used linear regression and Bayesian Kernel Machine Regression (BKMR) to estimate covariate-adjusted associations of individual EDCs and their mixtures with cardiometabolic indices during pregnancy. RESULTS: A 10-fold increase in BDE-28 was associated with a 13.1 mg/dL increase in glucose (95% Confidence Interval [CI] 2.9, 23.2) in linear regression. The BKMR model also identified BDE-28 as having a positive association with glucose. BDE-28, BDE-47, and BDE-99 were positively associated with total cholesterol in both single- and multi-pollutant models, whereas a suggestive negative association was noted with BDE-153. Mono-n-butyl phthalate (MBP) (β = −7.9 mg/dL, 95% CI −12.9, −3.0) and monobenzyl phthalate (MBzP) (β = −6.3 mg/dL, 95% CI −10.6, −2.0) were both associated with significant decreases in cholesterol in linear regression, but only MBzP was identified as an important contributor in the BKMR model. CONCLUSION: Overall, we observed positive associations between PBDEs with glucose and cholesterol levels during pregnancy, while negative associations were found between some phthalate biomarkers and cholesterol. No relationship was noted for BPA or PFAS with cardiometabolic indices during pregnancy across both models. 2021-07-19 2021-11 /pmc/articles/PMC8393591/ /pubmed/34425642 http://dx.doi.org/10.1016/j.envint.2021.106747 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC By-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Vuong, Ann M.
Braun, Joseph M.
Sjödin, Andreas
Calafat, Antonia M.
Yolton, Kimberly
Lanphear, Bruce P.
Chen, Aimin
Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study
title Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study
title_full Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study
title_fullStr Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study
title_full_unstemmed Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study
title_short Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study
title_sort exposure to endocrine disrupting chemicals (edcs) and cardiometabolic indices during pregnancy: the home study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393591/
https://www.ncbi.nlm.nih.gov/pubmed/34425642
http://dx.doi.org/10.1016/j.envint.2021.106747
work_keys_str_mv AT vuongannm exposuretoendocrinedisruptingchemicalsedcsandcardiometabolicindicesduringpregnancythehomestudy
AT braunjosephm exposuretoendocrinedisruptingchemicalsedcsandcardiometabolicindicesduringpregnancythehomestudy
AT sjodinandreas exposuretoendocrinedisruptingchemicalsedcsandcardiometabolicindicesduringpregnancythehomestudy
AT calafatantoniam exposuretoendocrinedisruptingchemicalsedcsandcardiometabolicindicesduringpregnancythehomestudy
AT yoltonkimberly exposuretoendocrinedisruptingchemicalsedcsandcardiometabolicindicesduringpregnancythehomestudy
AT lanphearbrucep exposuretoendocrinedisruptingchemicalsedcsandcardiometabolicindicesduringpregnancythehomestudy
AT chenaimin exposuretoendocrinedisruptingchemicalsedcsandcardiometabolicindicesduringpregnancythehomestudy